+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global and China Osteoporosis Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327729
  • Report
  • July 2020
  • Region: China, Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Amgen
  • Bone Biologics
  • Enzo Biochem, Inc.
  • JHL Biotech Inc.
  • Merck & Co.
  • Procter & Gamble
Osteoporosis is characterized by reduction in the density and quality of bones that often result in broken bones in the wrist, hip, and spine. Various factors responsible for osteoporosis include, genetic factors, low intake of calcium, magnesium, and vitamin D, eating disorders such as anorexia, inactivity and immobility, and excessive alcohol intake. Increasing approvals and launches of novel osteoporosis drugs along with increasing prevalence of osteoporasis is expected to significantly drive the osteoporosis treatment market growth over forecast period.

Key features of the study:
  • This report provides in-depth analysis of the Global and China Osteoporosis Drugs Market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global and China Osteoporosis Drugs Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Merck & Co., Eli Lilly, Procter & Gamble, Enzo Biochem, Inc., Sanofi-Aventis, Novartis, Wyeth, Roche, GlaxoSmithKline, UCB, Amgen, BeiGene Co., Ltd., Bone Biologics, Teijin Pharma Limited, JHL Biotech Inc., Keros Therapeutics, and Taro Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global and China Osteoporosis Drugs Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global and China Osteoporosis Drugs Market

Detailed Segmentation:

Global and China Osteoporosis Drugs Market, By Drug Type:
  • Bisphosphonates
  • Alendronate
  • Risedronate
  • Ibandronate
  • Zoledronic Acid
  • Others
  • Calcitonin
  • Hormone Therapy
  • Selective Estrogen Receptor Modulators (SERMs)
  • Parathyroid Hormone-Related Protein (PTHrP) Analog
  • Rank Ligand (RANKL) Inhibitor

Global and China Osteoporosis Drugs Market, By Route of Administration:
  • Oral
  • Injectable
  • Others

Global and China Osteoporosis Drugs Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Global and China Osteoporosis Drugs Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa

Company Profiles
  • Merck & Co. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
  • Eli Lilly
  • Procter & Gamble
  • Enzo Biochem, Inc.
  • Sanofi-Aventis
  • Novartis
  • Wyeth
  • Roche.
  • GlaxoSmithKline
  • UCB
  • Amgen
  • BeiGene Co., Ltd.
  • Bone Biologics
  • Teijin Pharma Limited
  • JHL Biotech Inc.
  • Keros Therapeutics
  • Taro Pharmaceuticals Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen
  • Bone Biologics
  • Enzo Biochem, Inc.
  • JHL Biotech Inc.
  • Merck & Co.
  • Procter & Gamble

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Country
  • Opportunity Map

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • Impact of COVID19 on market

4. Global and China Catheter Market, By Drug Type, 2019 - 2027, (US$ Bn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Bisphosphonates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Alendronate
  • Risedronate
  • Ibandronate
  • Zoledronic Acid
  • Others
  • Calcitonin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Hormone Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Selective Estrogen Receptor Modulators (SERMs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Parathyroid Hormone-Related Protein (PTHrP) Analog
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Rank Ligand (RANKL) Inhibitor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

5. Global and China Catheter Market, By Route of Administration, 2019 - 2027, (US$ Bn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

6. Global and China Catheter Market, By Distribution Channel, 2019 - 2027, (US$ Bn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

7. Global and China Catheter Market, By Region, 2019 - 2027, (US$ Bn)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • China
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Middle East
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Bn)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape
  • Company Profiles
  • Merck & Co.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eli Lilly
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Procter & Gamble
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Enzo Biochem, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sanofi-Aventis
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novartis
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Wyeth
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Roche
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • GlaxoSmithKline
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • UCB
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Amgen
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • BeiGene Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bone Biologics
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Teijin Pharma Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • JHL Biotech Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Keros Therapeutics
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Taro Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

9. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Merck & Co.
  • Eli Lilly
  • Procter & Gamble
  • Enzo Biochem, Inc.
  • Sanofi-Aventis
  • Novartis
  • Wyeth
  • Roche.
  • GlaxoSmithKline
  • UCB
  • Amgen
  • BeiGene Co., Ltd.
  • Bone Biologics
  • Teijin Pharma Limited
  • JHL Biotech Inc.
  • Keros Therapeutics
  • Taro Pharmaceuticals Inc.
Note: Product cover images may vary from those shown